Manufactured by ACON Laboratories Inc. in California, Flowflex is a rapid antigen self-test that doesn’t require a prescription. ACON was granted an emergency use authorization by the U.S. Food and Drug Administration on Oct. 4.
The companies announced on Dec. 23 that the combined resources of CLC and Alltests will increase the availability of COVID-19 home tests to consumers “through a proven and integrated distribution process.”
“Utilizing an innovative market penetration strategy, CLC has partnered with an international alliance of seasoned professionals in the medical, pharmaceutical, marketing, and entrepreneurial fields bonded by the mission to provide innovative, effective, and pragmatic solutions in the global battle against the COVID-19 pandemic,” the companies announced.[/vc_column_text][/vc_column][/vc_row]